Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug;47(4):559-564.
doi: 10.1016/j.anl.2020.06.003. Epub 2020 Jun 15.

ENT manifestation in COVID-19 patients

Mohammad Waheed El-Anwar  1 , Saad Elzayat  2 , Yasser Ahmed Fouad  3
Affiliations
Review

ENT manifestation in COVID-19 patients

Mohammad Waheed El-Anwar et al. Auris Nasus Larynx. 2020 Aug.

Abstract

Objective: to detect, analyze and discuss the different ear nose throat (ENT) manifestations those were reported in COVID19 positive patients in the reviewed and published literatures.

Methods: We performed a search in the PubMed databases, Web of Science, LILACS, MEDLINE, SciELO, and Cochrane Library using the keywords; COVID-19, Novel coronavirus, corona, 2019-nCoV, SARS-CoV-2, ENT, ear, nose, throat, otorhinolaryngology, ORL, pharynx, ORL, smell, larynx, different ENT related symptoms. We reviewed published and peer reviewed studies that reported the ENT manifestations in COVID-19 laboratory-confirmed positive patients.

Results: within the included 1773 COVID-19 laboratory-confirmed positive patients, the most common ENT manifestations of COVID-19 were sore throat (11.3%) and headache (10.7%). While the other reported ENT manifestations were pharyngeal erythema (5.3%), nasal congestion (4.1%), runny nose or rhinorrhea (2.1%), upper respiratory tract infection (URTI) (1.9%), and tonsil enlargement (1.3%).

Conclusion: ENT manifestations for COVID-19 are not common as fever and cough. But, a universal questionnaire using well-defined COVID-19 manifestations is needed to make the COVID-19 data precisely defined, complete and homogenous.

Keywords: COVID-19; ENT; corona virus; nasal manifestation; nose; otorhinolaryngology; pharynx.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare no conflict of interest and do not have any potential financial conflict of interest related to or could influence this work.

Figures

Fig 1:
Fig. 1
chart shows incidence of ENT manifestations in COVID-19 patients.
Fig 2:
Fig. 2
chart shows incidence of non-ENT manifestations in COVID-19 patients.
Fig 3:
Fig. 3
chart shows incidence of ENT and non ENT manifestations in COVID-19 patients.
See this image and copyright information in PMC

Comment in

References

    1. Xia W, Shao J, Guo Y, Peng X, Li Z, Hu D. Clinical and CT features in pediatric patients with COVID‐19 infection: different points from adults. Pediatr Pulmonol. 2020 May;55(5):1169–1174. - PMC - PubMed
    1. Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta bio-medica: Atenei Parmensis. 2020 Mar;91(1):157–160. - PMC - PubMed
    1. Drosten C, Günther S, Preiser W, Van Der Werf S, Brodt HR, Becker S. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003 May;348(20):1967–1976. - PubMed
    1. de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016 Aug;14(8):523. - PMC - PubMed
    1. Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis. 2020 Mar 13 - PMC - PubMed

MeSH terms